Corrections & Addendums
Drugs.com is committed to correcting errors that appear on our web site. Please contact us if you believe a correction or addendum is required.
Recent corrections
March 11, 2025
https://www.drugs.com/dosage/tafasitamab.html
Corrected to:
CYCLE 1: 12 mg/kg IV on Days 1, 4, 8, 15, and 22
CYCLE 2 and 3: 12 mg/kg IV on Days 1, 8, 15, and 22
CYCLE 4 and beyond: 12 mg/kg IV on Days 1 and 15
January 30, 2025
https://www.drugs.com/drug-interactions/amphetamine-index.html
missing benzphetamine, diethylpropion, methamphetamine, methylphenidate, phendimetrazine, phentermine
Correction: added missing drugs
https://www.drugs.com/drug-interactions/benzphetamine-index.html
missing dextroamphetamine
Correction: added missing drug
https://www.drugs.com/drug-interactions/dexfenfluramine-index.html
missing dexmethylphenidate and methylphenidate
Correction: added missing drugs
https://www.drugs.com/drug-interactions/dexmethylphenidate-index.html
missing fenfluramine and lorcaserin
Correction: added missing drugs
https://www.drugs.com/drug-interactions/dextroamphetamine-index.html
missing diethylpropion, lorcaserin, methamphetamine, methylphenidate, phendimetrazine and phentermine
Correction: added missing drugs
https://www.drugs.com/drug-interactions/fenfluramine-index.html
missing methylphenidate
Correction: added missing drug
https://www.drugs.com/drug-interactions/lisdexamfetamine-index.html
missing lorcaserin
Correction: added missing drug
https://www.drugs.com/drug-interactions/lorcaserin-index.html
missing methylphenidate
Correction: added missing drug
https://www.drugs.com/drug-interactions/sibutramine-index.html
missing dexmethylphenidate and methylphenidate
Correction: added missing drugs
January 14, 2025
https://www.drugs.com/dosage/dextromethorphan-guaifenesin.html
60/1200 per tablet: 1 to 2 tablets every 12 hours, maximum 4 tablets per day
Corrected to: 60/1200 per tablet: 1 tablet every 12 hours, maximum 2 tablets per day
October 31, 2024
https://www.drugs.com/sfx/vasopressin-side-effects.html
low blood pressure, dizziness, spinning sensation
Corrected to: Text removed.
October 24, 2024
https://www.drugs.com/disease-interactions/pregabalin.html
significantly elevated creating kinase levels
Corrected to: significantly elevated creatine kinase levels
October 22, 2024
https://www.drugs.com/dosage/pexidartinib.html
400 mg orally 2 times a day.
Corrected to: 250 mg orally 2 times a day. Take with a low-fat meal (approximately 11 to 14 grams of total fat).
September 6, 2024
https://www.drugs.com/dosage/etodolac.html
40 to 60 kg: 480 mg orally once a day
Corrected to: Weight 46 to 60 kg: 800 mg orally once a day
August 29, 2024
https://www.drugs.com/dosage/famotidine.html
-Usual dose: 0.5 mg/kg/day orally 2 times a day
Corrected to: 0.5 mg/kg orally 2 times a day
August 6, 2024
https://www.drugs.com/drug-class/cns-stimulants.html
List included pitolisant.
Corrected to: https://www.drugs.com/drug-class/miscellaneous-central-nervous-system-agents.html
July 31, 2024
https://www.drugs.com/food-interactions/sertraline.html
Missing recommendations for grapefruit and grapefruit juice.
Corrected to: taking sertraline with grapefruit or grapefruit juice is not recommended.
July 31, 2024
https://www.drugs.com/drug-interactions/ritonavir-index.html
Lisdexamfetamine missing from list.
Corrected to: Inclusion of lisdexamfetamine.
July 31, 2024
https://www.drugs.com/drug-interactions/dolutegravir-index.html
List included sodium bicarbonate.
Corrected to: Sodium bicarbonate removed.
July 24, 2024
https://www.drugs.com/food-interactions/selumetinib.html?professional=1
Selumetinib should be administered on an empty stomach at least 1 hour before or 2 hours after a meal.
Corrected to: Text removed.
July 9, 2024
https://www.drugs.com/interactions-check.php?drug_list=3867-0,2297-0
Abemaciclib may increase the blood levels of verapamil in some patients.
Corrected to: Verapamil may increase the blood levels of abemaciclib in some patients.
June 26, 2024
https://www.drugs.com/sfx/atorvastatin-side-effects.html
Text contained:
cardiovascular - Common (1% to 10%): Cardiovascular death
other 1 - Common (1% to 10%): Non-cardiovascular death
Corrected to: Text removed.
June 1, 2024
https://www.drugs.com/drug-class/cd38-monoclonal-antibodies.html
Category contained elranatamab.
Corrected to: https://www.drugs.com/drug-class/bispecific-t-cell-engagers-bite.html
https://www.drugs.com/drug-class/miscellaneous-antineoplastics.html
Category contained teclistamab and mosunetuzumab.
Corrected to: https://www.drugs.com/drug-class/bispecific-t-cell-engagers-bite.html
https://www.drugs.com/drug-class/cd20-monoclonal-antibodies.html
Category contained epcoritamab and glofitamab.
Corrected to: https://www.drugs.com/drug-class/bispecific-t-cell-engagers-bite.html
May 21, 2024
https://www.drugs.com/dosage/potassium-iodide.html
Over 3 months to 12 years: 65 mg orally once.
Corrected to: Over 3 years to 12 years: 65 mg orally once.
April 22, 2024
https://www.drugs.com/compare/fluticasone-salmeterol-vs-salmeterol
Inaccurate half life for salmeterol quoted as 264 hours.
Corrected to: 5.5 hours for salmeterol and 12.6 hours for fluticasone/salmeterol.
April 5, 2024
https://www.drugs.com/food-interactions/dronabinol.html
https://www.drugs.com/food-interactions/eplerenone.html
https://www.drugs.com/food-interactions/ifosfamide.html
https://www.drugs.com/food-interactions/levothyroxine.html
https://www.drugs.com/food-interactions/propafenone.html
https://www.drugs.com/food-interactions/upadacitinib.html
Missing drug-food interactions for grapefruit and grapefruit juice.
Corrected to: addition of updated drug-food interactions.
March 27, 2024
https://www.drugs.com/drug-interactions/peppermint-oil.html
Missing interactions.
Corrected to: addition of drug-food interaction and drug-drug interactions for antacids, H2 antagonists, and proton pump inhibitors.
March 19, 2024
https://www.drugs.com/mtm/aspirin-and-caffeine.html
Text contained references to treatment or prevention of heart attacks or strokes.
Corrected to: Text removed.
October 30, 2023
https://www.drugs.com/food-interactions/ozanimod.html
https://www.drugs.com/food-interactions/safinamide.html
Clarification of large amounts of tyramine.
Corrected to: very high levels of tyramine (greater than 150 mg).
June 14, 2023
https://www.drugs.com/drug-interactions/rimegepant-index.html
Identified missing drug-drug interaction.
Corrected to: addition of cannabidiol.
May 2, 2023
https://www.drugs.com/drug-interactions/ethanol,alcohol-contained-in-alcoholic-beverages-index.html
Identified missing drug-alcohol interactions.
Corrected to: Addition of the following drugs that interact with alcohol: captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, ramipril, trandolapril, enalaprilat, candesartan, eprosartan, irbesartan, losartan, olmesartan, valsartan, amlodipine, diltiazem, felodipine, isradipine, nicardipine, nifedipine, nisoldipine, verapamil.
April 14, 2023
https://www.drugs.com/sfx/gadobutrol-side-effects.html
Duplicated side effects incorrectly classified. dermatologic: Common (1% to 10%): Nausea Uncommon (0.1% to 1%): Vomiting Rare (less than 0.1%): Dry mouth
Corrected to: Text removed.
February 1, 2023
https://www.drugs.com/dosage/ketorolac.html
Incorrect dosage published. Usual Pediatric Dose for Pain Age: Greater than 17 years: Intranasal: -Maximum dose; weight less than 50 kg: 63 kg.
Corrected to: Maximum dose; weight less than 50 kg: 63 mg.
January 10, 2023
https://www.drugs.com/medical-answers/difference-between-vabysmo-eylea-3571792/
Incorrectly classified Vabysmo as an angiopoietin-1 (Ang-1) inhibitor.
Corrected to: angiopoietin-2 (Ang-2) inhibitor.
August 16, 2022
https://www.drugs.com/dosage/ixabepilone.html
https://www.drugs.com/mtm/ixabepilone.html
Incorrect dosage published. Usual Adult Dose for Breast Cancer: 140 mg/m2 IV over 3 hours every 3 weeks.
Corrected to: 40 mg/m2 IV over 3 hours every 3 weeks.
May 19, 2022
https://www.drugs.com/drug-interactions/semaglutide.html
Therapeutic duplication warnings for interactions combinations containing semaglutide (oral and injectable formulations) and other diabetes medicines. The therapeutic duplication warnings for the incretin mimetics currently include: 'antidiabetic drugs' (maximum three), 'oral antidiabetic medications' (maximum two), 'incretin-based therapies' (maximum one).
Corrected to: The therapeutic duplication warnings for the antidiabetic drugs currently include: 'antidiabetic drugs' (maximum three), The therapeutic duplication warnings for the non-insulin antidiabetic agents currently include: 'non-insulin antidiabetic agents' (maximum two)
February 11, 2022
https://www.drugs.com/drug-interactions/topiramate.html
Interactions between topiramate and hormonal contraceptives containing levonorgestrel, norethindrone, drospirenone, dienogest, and etonogestrel. No interactions found.
Corrected to: Topiramate may reduce the blood levels and effects of (levonorgestrel, norethindrone, drospirenone, dienogest, or etonogestrel), which may make it less reliable as a form of birth control. Alternative or additional methods of birth control should be used during treatment and for at least 28 days after discontinuing treatment with topiramate to avoid unintended pregnancy. This is particularly important because topiramate may cause harm in the unborn child. Talk to your gynecologist or other healthcare professional for help in selecting an effective method of birth control that is best for you. If you take hormone replacement for menopause, you should contact your doctor if you experience increased frequency or worsening of your symptoms such as hot flashes, vaginal dryness, or abnormal bleeding. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
February 15, 2022
https://www.drugs.com/interactions-check.php?drug_list=1971-0,1602-0
Interaction between pyridostigmine and methylcellulose. No interactions found.
Corrected to: Medications like methylcellulose may interfere with the absorption of pyridostigmine. It may be preferable to avoid using methylcellulose during treatment with pyridostigmine, or separate their times of administration by as much as possible to minimize the potential for interaction. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
February 11, 2022
https://www.drugs.com/mtm/calcifediol.html
Incorrect Indication. Calcifediol is used to treat hyperparathyroidism.
Corrected to: Calcifediol is used to treat secondary hyperparathyroidism
November 2, 2021
https://www.drugs.com/drug-interactions/gabapentin.html
Interactions between gabapentin and drugs containing diazepam, clonazepam, lorazepam, remimazolam, guanfacine, methyldopa, dexchlorpheniramine, chlorcyclizine, mephobarbital, cyclizine, dimenhydrinate, meclizine, melatonin, scopolamine, selegiline, levodopa, safinamide, and fenfluramine. No interactions found.
Corrected to: Using (drug listed above) together with gabapentin may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating. Some people, especially the elderly, may also experience impairment in thinking, judgment, and motor coordination. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
June 25, 2021
https://www.drugs.com/strattera.html
https://www.drugs.com/mtm/atomoxetine.html
https://www.drugs.com/qelbree.html
https://www.drugs.com/mtm/viloxazine.html
Incorrect drug class. CNS stimulants.
Corrected to: Adrenergic uptake inhibitors for ADHD
Last Updated: February 3, 2025
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.